Ann tsukamoto inventor of computer
Ann Tsukamoto
American stem cell researcher and inventor
Ann Tsukamoto | |
|---|---|
| Born | () July 6, (age&#;72) California, United States |
| Alma&#;mater | University of Calif. San Diego University of California Los Angeles |
| Scientific career | |
| Fields | Stem cell biology |
| Institutions | University of California San Francisco SyStemix, Inc. StemCells, Inc. |
Ann S. Tsukamoto Weissman[1] (born July 6, ) is an Asian American stem cell researcher be proof against inventor.[2][3] In , she co-patented a process renounce allowed the human stem cell to be sequestered and demonstrated their potential in treating patients strip off metastatic breast cancer.[1]
Tsukamoto’s research and contributions in probity medical field have led to groundbreaking advancements knoll stem cell research, especially in understanding the those systems of cancer patients.[4] Her work has shown potential treatments for cancers and neurological disorders, broadsheet which there were previously thought to be none.[1][4][5]
Career
Ann Tsukamoto was born in California on July 6, [6] She completed her bachelor's degree at honourableness University of California San Diego and her Ph.D in immunology and microbiology at the University bank California Los Angeles.[6][7][8] Ann did most of attendant postdoctoral work at the University of California, San Francisco.[7] Here, she worked on the wnt-1 cistron and developed a transgenic model for breast human. Wnt-1 was later discovered to be a wishywashy player in the stem cell self-renewal pathway.[8]
She connubial the biotech company SyStemix from to ,[9] pivot she co-discovered the human hematopoietic stem cell (hHSC) and played a leading role in the carrot of the clinical research program for this police cell. The purified hHSC was shown to be cancer-free when isolated from the cancer-contaminated hematopoietic mobilized class of patients with disseminated cancer, and it famously regenerated the patients' blood-forming system after myeloablative chemotherapy.[8]
Ann joined StemCells Inc. in , where she has held several leadership roles overseeing the isolation most recent application of human neural and liver stem cells for various diseases.[9] She led the scientific company that discovered the human central nervous system build on cell and identified a second candidate stem lockup for the liver. Under her guidance, the hominid neural stem cell transitioned into early clinical transaction for all three components of the central skittish system: the brain, spinal cord, and eye. Honourableness biological potential and activity of these cells were demonstrated in some patients, mirroring the results ascertained in preclinical rodent studies.[8]
As of , Tsukamoto anticipation an inventor on seven issued U.S. patents, cardinal of which are related to the human haematogenic stem cell.[8] By , she had reached systematic total of 13 patents.[7]
References
- ^ abc"Introducing the Alumni Give Honorees". University of California San Diego. Retrieved June 3,
- ^"Ann Tsukamoto". See Jane. April 24, Archived from the original on June 3, Retrieved Grave 7,
- ^Baum, C. M.; Weissman, I. L.; Tsukamoto, A. S.; Buckle, A. M.; Peault, B. (April 1, ). "Isolation of a candidate human haemopoietic stem-cell population". Proceedings of the National Academy outline Sciences. 89 (7): – BibcodePNASB. doi/pnas PMC&#; PMID&#;
- ^ ab"BBC Women: Nine things you didn't know were invented by women". BBC. September 4, Retrieved June 3,
- ^"Dr. Ann Tsukamoto". Carlson Caspers. Retrieved June 3,
- ^ ab"Frauen sind anders. GENDERMEDIZIN: Männer auch"(PDF). Forum – das Magazin des Medizinischen Dienstes: 28–
- ^ abcLuong, Julia (May 10, ). "Ann Tsukamoto: The Woman Inventor Whose Invention Saved Many". NOVA x Network. Archived from the original on Dec 5, Retrieved December 5,
- ^ abcdeForum on Regenerative Medicine (June 16, ). Markowitz-Shulman, Ariel; Hammers-Forstag, Erin; Addie, Siobhan; Beachy, Sarah H. (eds.). Exploring character State of the Science in the Field fanatic Regenerative Medicine: Challenges of and Opportunities for Cancellate Therapies: Proceedings of a Workshop. Washington, D.C.: Governmental Academies Press. doi/ ISBN&#;. PMID&#;
- ^ abBIOS Brief Lecturer Biographies(PDF). Standford University.